Interesting Blog post regarding the slow down in Spine and speculation as to who tomorrow's leaders will be.
Downgrading The Spine Market (The SpineBlogger)
To say that it has been a tumultuous and uncertain time in spine would be an understatement. Since the beginning of the year, the industry has been making adjustments to a rapidly changing U.S. healthcare landscape. In anticipation, downsizing began with Zimmer and Medtronic announcing layoffs, only to be followed by other key players such as Biomet and Alphatec. Granted, not all layoffs pertain to spine, but the industry has had its testosterone levels dropped a notch, and there is no need for a blood or saliva test. We are the enemy. Outside of Nuvasive, many companies are experiencing a dose of reality playing in a market where surgical procedures are down, insurance denials are up, patients are afraid to have surgery because they are worried about losing their jobs, and declining ASP's are making many of the larger companies reassess their financial objectives and distribution models.
In addition we have POD's threatening the existence of thousands of salespeople, blaming sales people for the high cost of delive...
